Question 1

What is the ESG rating for BDX?

Accepted Answer

Becton, Dickinson and Company has the following ESG ratings: MSCI ESG Rating: 87.06666666666666.

Question 2

What are the main strengths of investing in BDX?

Accepted Answer

The main strengths of investing in Becton, Dickinson and Company include: Strong environmental leadership surpassing emissions targets with 18% GHG reduction and pioneering medical device recycling programs, Direct positive healthcare impact through $1.08M community health grants and global medical technology innovation improving patient outcomes, Exceptional diversity recognition as Forbes Best Employer with robust financial performance generating $3.1B free cash flow.

Question 3

What are the potential drawbacks of investing in BDX?

Accepted Answer

Potential drawbacks of investing in Becton, Dickinson and Company include: Medical plastics waste challenge inherent to healthcare industry despite circular economy initiatives and recycling programs, Medium ESG risk rating and supply chain sustainability complexities across global medical device manufacturing operations, Stock volatility with significant decline from 52-week high amid healthcare industry regulatory pressures and market challenges.

Question 4

What are the key financial metrics for BDX?

Accepted Answer

Key financial metrics for Becton, Dickinson and Company include: Market Cap: $5.62 billion, Current Price: $360.45, Dividend Yield: 2.35%.

Becton, Dickinson and Company

Detailed View

BDX

ESG Ratings